how do you evaluate risks of ADE down the road from current vax products, particularly in light of this issue with coronavirus vaccines in general and sars-1 in particular?
based on an article on nih site recently it seems ade is not being specifically highlighted in the informed consent disclosure, but I have seen no one claim it is not a possibility. it seems like something people should be made aware of.
We are 20 months into COVID, and it is been over a year since the Pfizer large scale phase 3 trial started and ADE hasn't shown up yet for natural cases or vaccinations.